Multiple-Centre Clinical Evaluation of Rapid Recombinase-Aided Amplification Assays for Five Pathogens
Xinxin Shen(National Institute for Viral Disease Control and Prevention), Xuejun Ma(Xinjiang Agricultural University), JinRong Wang(Harrison International Peace Hospital), Linqing Zhao(Capital Institute of Pediatrics), Dan-wen Nie, Xiuge Rong(Tangshan Gongren Hospital), Zi-wei Chen(Central South University), Fei Xiao(Xidian University), Hao Li(Radboud University Nijmegen), Hong Zhang(Shanghai Jiao Tong University), Xinying Liu(University of South Africa), Ruiqing Zhang(National Institute for Viral Disease Control and Prevention), Ru-nan Zhu(Capital Institute of Pediatrics), Yuan Gao(Hebei Medical University), Xinna Li(National Institute for Viral Disease Control and Prevention), Xingyu Xiang(National Health and Family Planning Commission), Xueding Bai(National Institute for Viral Disease Control and Prevention), Zhifei Zhan(Hohai University), Lili Zhong(Fuzhou University)
Cited by 0
Related Papers
A Novel Coronavirus from Patients with Pneumonia in China, 2019
|New England Journal of Medicine|2020|30.5k
Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding
|The Lancet|2020|12.6k
Development and clinical application of a rapid IgM‐IgG combined antibody test for SARS‐CoV‐2 infection diagnosis
|Journal of Medical Virology|2020|1.9k
Fatty Liver Disease Caused by High-Alcohol-Producing Klebsiella pneumoniae
|Cell Metabolism|2019|521